Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)
Vinod A. Pullarkat, Terry B. Gernsheimer, Jeffrey S. Wasser, Adrian Newland, Troy H. Guthrie Jr, Joost Th. M. de Wolf, Ron Stewart, Dietmar BergerVolume:
84
Year:
2009
Language:
english
Pages:
3
DOI:
10.1002/ajh.21463
File:
PDF, 802 KB
english, 2009